IGF-1R as an anti-cancer target—trials and tribulations

por Chen, Helen X., Sharon, Elad
Publicado 2013

Sustained response of carcinoma ex pleomorphic adenoma treated with trastuzumab and capecitabine

por Sharon, Elad, Kelly, Ronan J, Szabo, Eva
Publicado 2010

Immune checkpoint inhibitors in clinical trials

por Sharon, Elad, Streicher, Howard, Goncalves, Priscila, Chen, Helen X.
Publicado 2014

Co-evolution based machine-learning for predicting functional interactions between human genes

por Stupp, Doron, Sharon, Elad, Bloch, Idit, Zitnik, Marinka, Zuk, Or, Tabach, Yuval
Publicado 2021

Apical ballooning and cardiomyopathy in a melanoma patient treated with ipilimumab: a case of takotsubo-like syndrome

por Geisler, Benjamin P, Raad, Roy A, Esaian, Diana, Sharon, Elad, Schwartz, David R
Publicado 2015

Incidence and survival of rare cancers in the US and Europe

por Botta, Laura, Gatta, Gemma, Trama, Annalisa, Bernasconi, Alice, Sharon, Elad, Capocaccia, Riccardo, Mariotto, Angela B.
Publicado 2020

Low-Dose Radiation Therapy for COVID-19: Promises and Pitfalls

por Venkatesulu, Bhanu P, Lester, Scott, Hsieh, Cheng-En, Verma, Vivek, Sharon, Elad, Ahmed, Mansoor, Krishnan, Sunil
Publicado 2020

ACE2 Co-evolutionary Pattern Suggests Targets for Pharmaceutical Intervention in the COVID-19 Pandemic

por Braun, Maya, Sharon, Elad, Unterman, Irene, Miller, Maya, Shtern, Anna Mellul, Benenson, Shmuel, Vainstein, Alexander, Tabach, Yuval
Publicado 2020

Organ Dysfunction in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors

por Spillane, Susan, Baxi, Shrujal, Torres, Aracelis Z., Lenis, David, Freedman, Andrew N., Mariotto, Angela B., Sharon, Elad
Publicado 2020

Ocular adverse events in PD-1 and PD-L1 inhibitors

por Young, LeAnne, Finnigan, Shanda, Streicher, Howard, Chen, Helen X, Murray, James, Sen, H Nida, Sharon, Elad
Publicado 2021

Developmental and temporal changes in petunia petal transcriptome reveal scent-repressing plant-specific RING–kinase–WD40 protein

por Shor, Ekaterina, Skaliter, Oded, Sharon, Elad, Kitsberg, Yaarit, Bednarczyk, Dominika, Kerzner, Shane, Vainstein, Danny, Tabach, Yuval, Vainstein, Alexander
Publicado 2023

CladeOScope: functional interactions through the prism of clade-wise co-evolution

por Tsaban, Tomer, Stupp, Doron, Sherill-Rofe, Dana, Bloch, Idit, Sharon, Elad, Schueler-Furman, Ora, Wiener, Reuven, Tabach, Yuval
Publicado 2021

Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development

por Tawbi, Hussein A, Sullivan, Ryan J, Feltquate, David, LaVallee, Theresa, Rizvi, Naiyer A, Sharon, Elad, Sosman, Jeffrey, Kluger, Harriet M
Publicado 2023

Checkpoint inhibitor immunotherapy during pregnancy for relapsed–refractory Hodgkin lymphoma

por Evens, Andrew M., Brandt, Justin S., Peer, Cody J., Yin, Tyler, Schaar, Dale, Farooq, Faheem, Mozarsky, Brett, Figg, William D., Sharon, Elad
Publicado 2022

Assessment of Cancer Therapy Evaluation Program Advocacy and Inclusion Rates of People Living With HIV in Anti–PD1/PDL1 Clinical Trials

por Reuss, Joshua E., Stern, Diana, Foster, Jared C., Ramaswami, Ramya, Lurain, Kathryn, Chen, Helen X., Streicher, Howard, Kem, Ravie, Little, Richard F., Sharon, Elad
Publicado 2020

Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors

por Kluger, Harriet, Barrett, J Carl, Gainor, Justin F, Hamid, Omid, Hurwitz, Michael, LaVallee, Theresa, Moss, Rebecca A, Zappasodi, Roberta, Sullivan, Ryan J, Tawbi, Hussein, Sharon, Elad
Publicado 2023

The Cancer Moonshot Immuno-Oncology Translational Network at 5: accelerating cancer immunotherapies

por Annapragada, Ananth, Sikora, Andrew G, Marathe, Himangi, Liu, Song, Demetriou, Michael, Fong, Lawrence, Gao, Jinming, Kufe, Donald, Morris, Zachary S, Vilar, Eduardo, Sharon, Elad, Hutson, Alan, Odunsi, Kunle
Publicado 2023

Cross-species identification of cancer resistance–associated genes that may mediate human cancer risk

por Nair, Nishanth Ulhas, Cheng, Kuoyuan, Naddaf, Lamis, Sharon, Elad, Pal, Lipika R., Rajagopal, Padma S., Unterman, Irene, Aldape, Kenneth, Hannenhalli, Sridhar, Day, Chi-Ping, Tabach, Yuval, Ruppin, Eytan
Publicado 2022

Trial Reporting in Immuno-Oncology (TRIO): an American society of clinical oncology-society for immunotherapy of cancer statement

por Tsimberidou, Apostolia M., Levit, Laura A., Schilsky, Richard L., Averbuch, Steven D., Chen, Daniel, Kirkwood, John M., McShane, Lisa M., Sharon, Elad, Mileham, Kathryn F., Postow, Michael A.
Publicado 2018

Species‐complex diversification and host‐plant associations in Bemisia tabaci: A plant‐defence, detoxification perspective revealed by RNA‐Seq analyses

por Malka, Osnat, Santos‐Garcia, Diego, Feldmesser, Ester, Sharon, Elad, Krause‐Sakate, Renate, Delatte, Hélène, van Brunschot, Sharon, Patel, Mitulkumar, Visendi, Paul, Mugerwa, Habibu, Seal, Susan, Colvin, John, Morin, Shai
Publicado 2018